Anti-SARS-CoV-2 Equine Immunoglobulin Fragments F(ab')2
Anti-SARS-CoV-2 Equine Immunoglobulin Fragments F(ab')2 Uses, Dosage, Side Effects, Food Interaction and all others data.
Anti-SARS-CoV-2 Equine Immunoglobulin Fragments F(ab')2, also known as INOSARS, is a polyvalent passive immunization being tested in the clinical trial NCT04514302 (Safety and Efficacy of Anti-SARS-CoV-2 Equine Antibody Fragments (INOSARS) for Hospitalized Patients With COVID-19). INOSARS is composed of F(ab’)2 fragments extracted from hyperimmune equine serum.
| Trade Name | Anti-SARS-CoV-2 Equine Immunoglobulin Fragments F(ab')2 |
| Generic | Anti-SARS-CoV-2 equine immunoglobulin fragments |
| Anti-SARS-CoV-2 equine immunoglobulin fragments Other Names | Anti-SARS-CoV-2 equine immunoglobulin fragments F(ab')2, INOSARS |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Anti-SARS-CoV-2 Equine Immunoglobulin Fragments F(ab')2
